Targeted Molecular Diagnostics, LLC
Records under this name other than patents Targeted Molecular Diagnostics, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 3 of 3 · Back to Targeted Molecular Diagnostics, LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,862,995 | Methods and Materials for Predicting Responsiveness to Treatment with Dual Tyrosine Kinase Inhibitor Lapsed on the fee record Ended Jan 4, 2019 · High confidence | Lapsed on the fee record | Ended Jan 4, 2019 | High confidence |
| US 8,709,738 | Methods for Predicting Cardiac Toxicity Formerly held Lapsed on the fee record Ended Apr 29, 2018 · High confidence | Lapsed on the fee record | Ended Apr 29, 2018 | High confidence |
| US 8,623,604 | Methods for Predicting Responsiveness of a Cancer Cell to an ANTI-IGFR1 Antibody by Analysis of Mutations in PIK3CA Formerly held Lapsed on the fee record Ended Jan 7, 2018 · High confidence | Lapsed on the fee record | Ended Jan 7, 2018 | High confidence |